Intel Corp (INTC) JPMorgan Raises Target Valuation on Strong Q3

Intel Corp. (INTC) Bernstein Suggests Stock is Overvalued

Intel Corp (INTC) 

Analyst Update

JPMorgan has raised its 12 month price target on Intel Corp (INTC) to $30 from $21 following stronger-than-expected third-quarter results, marking a significant turnaround in sentiment for the semiconductor giant. The upgrade reflects renewed confidence in Intel’s ability to stabilize core operations, supported by robust demand in the PC and data center segments, even as the company continues to navigate ongoing supply chain constraints and industry competition.

Stock Forecast & Analysis

Technically, Intel’s chart shows strengthening momentum ehich exhibits a “Strong Buy” signal. The stock has established firm support near its recent lows, with improving relative strength indicating that buying interest is returning to the name. However, given the stock’s recent rally, near-term volatility remains a possibility as investors assess sustainability in margins and product competitiveness.

On the fundamental side, Intel’s results demonstrate early signs that CEO Pat Gelsinger’s turnaround strategy, centered on expanding manufacturing capacity, optimizing product mix, and improving cost efficiency is beginning to gain traction. The company’s foundry expansion and reorganization efforts position it for long-term growth as global semiconductor demand recovers and governments invest in domestic chip production capacity.

Despite the positive momentum, the consensus analyst rating remains “Neutral”, reflecting continued caution regarding execution risks, margin pressures, and the timeline for meaningful profitability improvements in Intel’s manufacturing business. The average 12 month price target of $35.00 per share, implies a downside of roughly 8% from current trading levels, suggesting the market may have priced in much of the near-term optimism.

Intel’s short-term prospects are supported by improving fundamentals and technical strength, but the medium-term outlook remains balanced, as investors wait for consistent earnings growth and competitive positioning against peers like AMD and NVIDIA. The company’s recovery trajectory appears promising, but execution on its manufacturing roadmap will remain the key determinant of sustained shareholder value.

Ad